Gilead Sciences is a top biopharma company active in partnering, licensing and M&A in biopharmaceuticals.
Scientific breakthrough is almost always the product of collaboration and Gilead places high value on partnering with companies and organizations whose strengths complement and augment our own.
Over the past two decades, Gilead have forged many long-term collaborations with leading academic institutions and biotechnology and pharmaceutical companies to develop innovative new therapeutics and advance the care of patients confronting life-threatening diseases.
Summary of Gilead Sciences partnering interests
Gilead Sciences partnering interests are not disclosed directly; however we can generally assume their interests are reflected in their existing pipeline and recent partnering activity.
This can be summarised as follows:
- Liver disease
For the latest detail on Gilead’s partnering interests, visit the business partnerships section of Gilead website > go to About Gilead > Business Partnerships for details.
Gilead Sciences are routinely present at a large number of partnering events throughout the year.
Partnering events are a great place to meet lots of potential partners face to face in a small amount of time.
Events with Gilead presence include but are not limited to:
- BIO International Convention and Business Forum
- BioEurope / BioEurope Spring
For a full list of forthcoming partnering events where you could meet with Gilead in person visit Current Partnering’s Event calendar.
In addition, you can find a full list of events where Gilead will be present for partnering discussions, visit the partnering section of Gilead website > go to About Gilead > Business Partnerships for details.
Contacting Gilead Sciences for partnering
Gilead Sciences can be contacting in relation to partnering through a number of channels.
Here is a list of the most common channels:
Partnering events: face to face contact is generally considered the most effective form of contact. Partnering events not only allow face to face contact but also contact with multiple companies for the price of one flight and hotel reservation. This benefit makes partnering events the most cost effective method of making personal introductions as a start point for partnering discussions.
Direct contact: there are several sources of direct contact with Gilead business development team
- Phone: Picking up the phone and speaking with an individual is the best form of non-face to face contact as it allows your name and voice to be remembered and associated with an opportunity.
- Email: Sending an email is another good way of making contact. Ideally, research the individual responsible for the therapy/technology area being targeted and get in touch. Gilead do not publish a list of contacts on their website, so unless you cannot find a direct contact elsewhere use the contact email here.
- LinkedIn: Business to business contact is increasingly taking place via LinkedIn, the global online networking channel. Many of Gilead business development executives have LinkedIn profiles and can be found by viewing the company’s profile. Visit Gilead LinkedIn page
Opportunity submission form: the least favourable channel but worth using if you do not have access to the other channels mentioned above. Gilead provides an email address and postal address which can be found by partnering section of Gilead website > go to About Gilead > Business Partnerships for details.
Available reports from Current Partnering
Report: Partnering Deals and Alliances with Gilead Sciences
Available resources for deal coverage for Gilead
Read: more on Gilead Sciences company profile, recent partnering, M&A and financing news and articles
Report: Practical Guide to Finding Partners
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk